{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:51:18Z","timestamp":1791143478178,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.jns.2008.05.002","type":"journal-article","created":{"date-parts":[[2008,6,12]],"date-time":"2008-06-12T13:42:38Z","timestamp":1213278158000},"page":"99-105","source":"Crossref","is-referenced-by-count":98,"title":["Effect of infliximab in progressive Neuro-Beh\u00e7et's syndrome"],"prefix":"10.1016","volume":"272","author":[{"given":"Hirotoshi","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Aramaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsei","family":"Hirohata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2008.05.002_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/ar757","article-title":"Beh\u00e7et's disease","volume":"5","author":"Hirohata","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jns.2008.05.002_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s004150050205","article-title":"Beh\u00e7et's disease and the nervous system","volume":"245","author":"Serdaroglu","year":"1998","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2008.05.002_bib3","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/brain\/122.11.2183","article-title":"Neurological complications in Beh\u00e7et's syndrome","volume":"122","author":"Kidd","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.jns.2008.05.002_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00019052-200406000-00017","article-title":"Beh\u00e7et's syndrome and the nervous system","volume":"17","author":"Siva","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jns.2008.05.002_bib5","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","article-title":"Clinical patterns of neurological involvement in Beh\u00e7et's disease: evaluation of 200 patients. The Neuro-Beh\u00e7et Study Group","volume":"122","author":"Akman-Demir","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.jns.2008.05.002_bib6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0022-510X(00)00403-2","article-title":"Cerebrospinal fluid beta(2)-microglobulin in neuro-Behcet's syndrome","volume":"179","author":"Kawai","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2008.05.002_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/clin.1996.4268","article-title":"Cerebrospinal fluid interleukin-6 in progressive Neuro-Behcet's syndrome","volume":"82","author":"Hirohata","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jns.2008.05.002_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-510X(98)00165-8","article-title":"Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Beh\u00e7et's disease","volume":"159","author":"Hirohata","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2008.05.002_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/0-306-48382-3_117","article-title":"Low dose MTX for progressive neuro-Beh\u00e7et's disease. A follow-up study for 4\u00a0years","volume":"528","author":"Kikuchi","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jns.2008.05.002_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/cyto.1995.0029","article-title":"Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions","volume":"7","author":"Scallon","year":"1995","journal-title":"Cytokine"},{"key":"10.1016\/j.jns.2008.05.002_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/rheumatology\/40.4.473","article-title":"Treatment of recalcitrant orogenital ulceration of Beh\u00e7et's syndrome with infliximab","volume":"40","author":"Robertson","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.jns.2008.05.002_bib12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/ard.60.6.637","article-title":"Remission of Beh\u00e7et's syndrome with tumour necrosis factor alpha blocking therapy","volume":"60","author":"Goossens","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jns.2008.05.002_bib13","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1053\/gast.2001.22556","article-title":"Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Beh\u00e7et's disease: a case report","volume":"120","author":"Hassard","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jns.2008.05.002_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","article-title":"Effect of infliximab on sight-threatening panuveitis in Beh\u00e7et's disease","volume":"358","author":"Sfikakis","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2008.05.002_bib15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/ard.62.3.280","article-title":"Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Beh\u00e7et's syndrome","volume":"62","author":"Licata","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jns.2008.05.002_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.2006.056804","article-title":"Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile","volume":"66","author":"Fujikawa","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jns.2008.05.002_bib17","first-page":"1078","article-title":"Criteria for diagnosis of Behcet's disease","volume":"335","author":"International Study Group for Behcet's disease","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2008.05.002_bib18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1468-1331.2007.02008.x","article-title":"Brainstem in Machado-Joseph disease: atrophy or small size?","volume":"15","author":"Horimoto","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jns.2008.05.002_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/157339707782408973","article-title":"Potential new therapeutic options for involvement of central nervous system in Behcet's disease (Neuro-Behcet's syndrome)","volume":"3","author":"Hirohata","year":"2007","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.jns.2008.05.002_bib20","first-page":"1362","article-title":"Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Beh\u00e7et's disease with refractory uveoretinitis","volume":"31","author":"Ohno","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jns.2008.05.002_bib21","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/art.21231","article-title":"Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Beh\u00e7et's disease: an open-label trial","volume":"52","author":"Tugal-Tutkun","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jns.2008.05.002_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2007.09.041","article-title":"Histopathology of central nervous system of Beh\u00e7et's disease","volume":"267","author":"Hirohata","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2008.05.002_bib23","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.47.6.1531","article-title":"Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2","volume":"47","author":"van Oosten","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.05.002_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1517\/14740338.3.5.391","article-title":"Considerations with the use of biological therapy in the treatment of rheumatoid arthritis","volume":"3","author":"Fleischmann","year":"2004","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jns.2008.05.002_bib25","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/rheumatology\/kem034","article-title":"Anti-TNF therapy in the management of Behcet's disease\u2013review and basis for recommendations","volume":"46","author":"Sfikakis","year":"2007","journal-title":"Rheumatology (Oxford)"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08002189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08002189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T08:43:54Z","timestamp":1709023434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X08002189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":25,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0022510X08002189"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2008.05.002","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}